Recurrent Circulatory Stress: The Dark Side of Dialysis

Seminars in Dialysis

Volumn 23, Issue 5, 2010, Pages 449-451

  Mcintyre, Christopher W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DISEASE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; EDITORIAL; GASTROINTESTINAL DISEASE; HUMAN; HYPOTENSION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; RECURRENT DISEASE; RENAL REPLACEMENT THERAPY;

BRAIN DISEASES; CARDIOVASCULAR DISEASES; GASTROINTESTINAL DISEASES; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; OXYGEN CONSUMPTION; PHENOTYPE; RECURRENCE; RENAL DIALYSIS;

EID: 78049420484     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2010.00782.x     Document Type: Editorial

References (36)

1. Bos WJ, Bruin S, Van Olden RW, Keur I, Wesseling KH, Westerhof N, Kriedert J, Arsiz LA: Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis 35:819-826, 2000
2. Mcintyre CW: Effects of hemodialysis on cardiac function. Kidney Int 76:371-375, 2009
3. Burton JO, Jefferies HJ, Selby NM, Mcintyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4:914-920, 2009
4. Harrison LEA, Selby NM, Mcintyre CW: Central venous oxygen saturation: a potential new marker for circulatory stress in haemodialysis patients. Abstract ASN 2010
5. Kingwell BA, Waddell TK, Medley TL, Cameron JD, Dart AM: Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol 40:773-779, 2002
6. Mcintyre CW: Haemodialysis-induced myocardial stunning in chronic kidney disease - a new aspect of cardiovascular disease. Blood Purif 29:105-110, 2010
7. Selby NM, Mcintyre CW: The acute cardiac effects of dialysis. Semin Dial 20:220-228, 2007
8. Jefferies HJ, Virk B, Doss S, Sun S, John SG, Moran J, Schiller B, Mcintyre CW: Frequent haemodialysis regimens are associated with reduction in dialysis-induced myocardial stunning and systemic inflammation. Clin J Am Soc Nephrol 2010, in press
9. Selby NM, Lambie SH, Camici PG: Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 47:830-841, 2006
10. Selby NM, Burton JO, Mcintyre CW: Dialysis induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 1:1216-1225, 2006
11. Rakowski DA, Caillard S, Agodoa LY, Abbott KC: Dementia as a predictor of mortality in dialysis patients. Clin J Am Soc Nephrol 1:1000-1005, 2006
12. Nakatani T, Naganuma T, Uchida J, Masuda C, Wada S, Sugimura T, Sugimura K: Silent cerebral infarction in hemodialysis patients. Am J Nephrol 23:86-90, 2003
13. Anan F, Shimomura T, Imagawa M, Masaki T, Nawata T, Takahashi N, Yonemochi H, Eshima N, Saikawa T, Yoshimatsu H: Predictors of silent infarction in patients with chronic renal failure undergoing hemodialysis. Metab Clin Exp 56:593-598, 2007
14. Anan F, Shimomura T, Kaku T, Kaneda K, Imagawa M, Masaki T, Nawata T, Yonemochi H, Eshima N, Yoshimatsu H: High-sensitivity C-reactive protein level is a significant risk factor for silent cerebral infarction in patients on hemodialysis. Metab Clin Exp 57:66-70, 2008
15. Prohovnik I, Post J, Uribarri J, Lee H, Sandu O, Langoff E: Cerebrovascular effects of hemodialysis in chronic kidney disease. J Cereb Blood Flow Metab 27:1861-1869, 2007
16. Kim CD, Lee HJ, Kim DJ, Kim BS, Shin SK, Do JY, Jang MH, Park SH, Kim YS, Kim Yl: High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis 50:98-107, 2007
17. Lamar M, Catani M, Price CC, Heilman KM, Libon DJ: The Impact of region-specific Leukoaraiosis on working memory deficit in dementia. Neurophsycologia 46:2597-2601, 2008
18. Onen F, Henry-Feugeas MC, Roy C, Baron G, Ravaud P: Mobility decline of unknown origin in mild cognitive imairment: an MRI-based clinical study of the pathogenesis. Brain Res 1222:79-86, 2008
19. Pereira AA, Weiner DE, Scott T, Chandra P, Bluestein R, Griffiths J, Sarnar MJ: Subcortical cognitive impairment in dialysis patients. Hemodial Int 11:309-314, 2007
20. Lamar M, Charlton RA, Morris RG, Markus HS: The impact of subcortical white matter disease on mood in euthymic older adults: a diffusion tensor imaging study. Am J Geriatr Psychiatry 18:634-642, 2010
21. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE: Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361:1539-1547, 2009
22. Charalambous BM, Stephens RC, Feavers IM, Montgomery HE: Role of bacterial endotoxin in chronic heart failure: the gut of the matter. Shock 28:15-23, 2007
23. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284-288, 1998
24. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ: Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 79:1426-1430, 1997
25. Krack A, Sharma R, Figulla HR, Anker SD: The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 26:2368-2374, 2005
26. Sandek A, Baudiz J, Swidsinski A, Buhner S, Weber-Ebel J, Von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M, Poole-Wilson P, Volk HD, Lochs H, Anker SD: Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50:1561-1569, 2007
27. Niebauer J, Volk HD, Kemp M, Dominguez M, Schuman RR, Ravchhaus M, Poole-Wilson PA, Coats AJ, Anker SD: Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353:1838-1842, 1999
28. Peschel T, Schonauer M, Thiele H, Anker SD, Schuler G, Niebauer J: Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail 5:609-614, 2003
29. Diebel L, Kozol R, Wilson RF, Mahajan S, Abu-Hamdan D, Thomas D: Gastric intramucosal acidosis in patients with chronic kidney failure. Surgery 113:520-526, 1993
30. Yu AW, Nawab ZM, Barnes WE, Lai KN, Ing TS, Daugirdas JT: Splanchnic erythrocyte content decreases during hemodialysis: a new compensatory mechanism for hypovolemia. Kidney Int 51:1986-1990, 1997
31. Jakob SM, Rvokenen E, Vuolteenaho O, Lampainen E, Takala J: Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion. Crit Care Med 29:1393-1398, 2001
32. Khanna A, Rossman JE, Fung Hl, Caty MG: Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion. J Surg Res 99:114-119, 2001
33. Mcintyre CW, Harrison LEA, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PKT: Circulating endotoxaemia: a previously unrecognised factor in the pathophysiology of systemic inflammation and cardiovascular disease in chronic kidney disease patients. J Am Soc Nephrol 2010, in press
34. Shemin D, Bostom AG, Laliberty P, Dworkin LD: Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38:85-90, 2001
35. Rottembourg J, Issad B, Gallego Jl, Degoulet P, Aime F, Gueffat B, Legrain M: Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 19:397-403, 1983
36. Mcintyre CW: Bimodal dialysis: an integrated approach to renal replacement therapy. Perit Dial Int 24:547-553, 2004